Bernstein SocGen cuts Pepsico stock price target on share losses

Bernstein SocGen cut PepsiCo’s price target to $142 from $143 (Market Perform) while forecasting ~2% YoY EPS growth, which is ~4% below consensus for next-twelve-months-plus-one. The downgrade/estimate pressure is tied to PepsiCo’s snacks being the most challenged category in its coverage universe (loss of market share) and beverages seeing share losses that weigh on organic momentum, with North America weakness only partially offset by a stronger international business. Offsetting positives include a 4% quarterly dividend increase to $1.48/share (annualized $5.92), but multiple analyst TP trims (e.g., TD Cowen) keep near-term risk skewed to the downside as the stock trades near its 52-week low.

Analysis

This reads less like a one-off analyst tweak and more like the market slowly reclassifying PEP from a dependable compounder into a low-growth defensive with deteriorating category share. When a franchise is losing share in both its core segments, dividend growth stops being a growth signal and becomes a valuation crutch; that usually invites multiple compression if organic sales fail to outgrow inflation and promo intensity rises. The second-order implication is that retailers and distributors can demand more trade spend to protect shelf velocity, which would leak straight into margin before any meaningful volume recovery.

Near term, the key swing factor is not the target-price debate but whether the next few months of scanner data confirm continued share loss in North American snacks and beverages. If that persists, the stock can underperform even with a near-3% yield because income buyers tend to defend the name only until EPS revision breadth turns decisively negative; after that, the market starts pricing a lower steady-state growth rate. On the other hand, if management can show stabilizing depletion trends, the name could bounce mechanically from oversold levels since it is already near a multi-year valuation floor.

The contrarian point is that consensus may be underestimating how sticky brand erosion can be once a staple loses velocity in multiple subcategories simultaneously. A 16x multiple is not obviously cheap if the business is drifting toward low-single-digit EPS growth and higher promotional burden, especially versus peers with cleaner category exposure. The downside is probably more about time than price: the thesis weakens only if North American organic growth re-accelerates or if management guides back to mid-single-digit EPS growth over the next 1-2 quarters.

Key Decisions for Investors

• Relative-value short PEP vs long KO or MDLZ over the next 1-3 months: PEP has the more visible share-loss problem, while KO/MDLZ have cleaner category positioning and better odds of defending multiples. Use this as a spread trade rather than an outright short; thesis is wrong if PEP stabilizes volumes and raises FY organic sales guidance.
• If you want directional exposure, buy a 3-6 month PEP 130/120 put spread only on a rally back toward the low-140s. That keeps risk defined and targets a continued derating toward the 52-week low zone; invalidate above $145 with improving scanner data.
• Do not chase the dividend as a support thesis alone. Income demand can slow the downside, but if EPS revisions keep drifting lower, the stock can still de-rate 1-2 turns over the next quarter; use any rebound as an exit opportunity rather than averaging down.
• Watch TGT and the broader consumer-discretionary/consumer-staples channel for read-through rather than treating this as a standalone PEP event. If packaged-food weakness is really a grocery basket demand issue, TGT food/consumables comps and traffic could soften further; if not, this stays a company-specific short.